The aim of this study was to evaluate the effects of ginger consumption on blood glucose levels in patients with type 2 diabetes (T2D). The main finding of the study was that patients who consumed ginger had improved blood sugar control.

The aim of this study was to investigate the safety and effectiveness of pioglitazone in the treatment of type 2 diabetes (T2D). The main finding of the study was that pioglitazone was an effective treatment of T2D.

This study explored the frequency of remaining pain in those with early rheumatoid arthritis (RA) after three months of treatment with methotrexate (Trexall). The results showed that remaining pain was common after treatment. 

The aim of this study was to examine the safety and effectiveness of adding semaglutide to SGLT-2 therapy in type 2 diabetes (T2D). The main finding of the study was that adding semaglutide to SGLT-2 therapy significantly improved blood sugar control and decreased body weight in patients with T2D.

The aim of this study was to investigate the effectiveness of cetrorelix in rheumatoid arthritis (RA) patients with high gonadotropin hormone levels.

This study examined the link between rheumatoid arthritis (RA) and weakened kidney function. The authors concluded that poor kidney function is common in patients with RA and is linked to age, high blood pressure, and cardiovascular risk factors.

The aim of this study was to identify the risk factors for diabetic eye disease (retinopathy) in patients with type 1 diabetes (T1D). The main finding of the study was that poor blood sugar control, high levels of protein in the urine and high blood pressure were risk factors for diabetic retinopathy (DR) in T1D.

The aim of this study was to investigate the risk of metabolic syndrome after pregnancy in women that had gestational diabetes (GD). The main finding of the study was women who had GD had a higher risk of metabolic syndrome after pregnancy.

This study examined the effectiveness of peficitinib in patients with moderate to severe rheumatoid arthritis. The results showed that this new drug was safe and effective.

This study examined link between age and gender and cardiovascular risk in patients with rheumatoid arthritis (RA). The authors concluded that the risk of cardiovascular disease is higher in all RA patients than in the general population. They also determined that the risk is highest in RA patients under 50.